Axsome Therapeutics received a refusal-to-file letter from the Food and Drug Administration for its new drug application for its fibromyalgia drug AXS-14.

Axsome Therapeutics, Inc. , a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it has received a Refusal to File (RTF) letter ...

Protesters clashed with law enforcement in Los Angeles on Sunday after Trump deployed National Guard troops over the ...

California Gov. Gavin Newsom pushed back against threats of arrest by Trump administration officials, remaining defiant as he ...

The FDA has issued its first ever approval on a safety consultation for lab-grown fish. That makes Wildtype only the fourth ...

Health insurance premiums for Idaho state employees and their dependents will increase sharply due to rising health care ...

The US and China will restart trade talks in London on Monday, aiming to ease tensions over rare earths and tech after ...

Iowa native Joseph Welch said, "Have you no decency, sir?" and we need people with his courage today, writes Thomas Doughty.